Matthew “Tex” VerMilyea, PhD, HCLD/CC, Vice President of Scientific Advancement
As Ovation Fertility’s Vice President of Scientific Advancement, Matthew “Tex” VerMilyea serves as a scientific resource and operational advocate for the nationwide network of US Fertility and Ovation IVF laboratories.
In this role, he facilitates clinical collaboration across the network’s laboratory teams, while building existing and new relationships within the fertility care community, securing US Fertility and Ovation’s leadership role in accessing and further developing the latest technologies and research. Dr. VerMilyea is also uniquely positioned to evaluate procedures and outcomes and develop best practices to continuously improve performance across the scientific teams.
A recognized leader in the IVF research community
Dr. VerMilyea is board certified as both a clinical consultant and a high complexity clinical laboratory director. He is well-known within the IVF research community for leading innovative, collaborative studies to advance the science of fertility care, including award-nominated research involving the use of artificial intelligence in IVF. He is frequently invited to present these collaborative studies’ findings at the largest fertility care conferences in the United States and abroad.
Dr. VerMilyea received a bachelor of science degree from Cornell University and his PhD in epigenetics from The University of Birmingham in the United Kingdom. He then completed post-doctoral fellowships in the chromatin and gene expression laboratories at the Institute of Biomedical Research in Birmingham, UK. He later was selected as a research fellow for the Japan Society for the Promotion of Science, where he completed a second fellowship in the Laboratory of Mammalian Molecular Embryology at the RIKEN Institute in Kobe, Japan. Maintaining his foundation in genetic and molecular research, he chose to return to clinical human IVF and develop a career as an accomplished embryologist, laboratory director, and scientific collaborator.
Dr. VerMilyea has performed extensive IVF research in non-invasive artificial intelligence applications, preimplantation genetic testing methodology, embryo culture protocols, selective single embryo transfers, enhanced sperm selection, and the vitrification (freezing) and preservation of eggs, embryos, and reproductive tissue. He has positively influenced the field of reproductive medicine as an instructor at the University of Pennsylvania, honorary research associate at Victoria University of Wellington, New Zealand, and honorary lecturer at Auckland University, New Zealand.